ATHX Athersys Inc

Athersys Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.

$0.19  +0.01 (4.38%)
As of 05/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/12/2007
Outstanding shares:  251,967,791
Average volume:  7,511,989
Market cap:   $46,588,845
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B1YH8W1
Valuation   (See tab for details)
PE ratio:   -0.81
PB ratio:   193.00
PS ratio:   16.00
Return on equity:   -26,939.09%
Net income %:   -2,839.37%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy